First Trust Nasdaq Pharmaceuticals ETF (FTXH)
About this ETF
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.
Price
Top 10 holdings
| Eli Lilly and Company LLY | 7.67% |
| AbbVie Inc. ABBV | 7.26% |
| Johnson & Johnson JNJ | 7.02% |
| Merck & Co., Inc. MRK | 6.77% |
| Bristol-Myers Squibb Company BMY | 6.27% |
| Viatris Inc. VTRS | 3.70% |
| Biogen Inc. BIIB | 3.52% |
| Cardinal Health, Inc. CAH | 3.49% |
| Vertex Pharmaceuticals Incorporated VRTX | 3.32% |
| Amgen Inc. AMGN | 3.18% |
Sector mix
Price chart
Returns
| 1 month | +8.24% |
| 3 months | +12.37% |
| 6 months | +13.88% |
| Year to date | +16.09% |
| 1 year | +42.63% |
| 3 years (ann.) | +13.91% |
| 5 years (ann.) | +7.86% |
| 10 years (ann.) | — |
Risk profile
| Volatility (1y, ann.) | 17.70% |
| Sharpe (1y) | 2.10 |
| Sharpe (3y) | 0.86 |
| Sortino (1y) | 4.07 |
| Max drawdown (1y) | -7.47% |
| Max drawdown (5y) | -20.53% |
| Max drawdown (full) | -32.10% |
| Beta vs S&P 500 (1y) | 0.47 |
| Correlation vs S&P 500 (1y) | 0.33 |
Technical outlook as of 2026-07-13
The Monte Carlo cone is drawn on the price chart above (Forecast overlay); RSI, MACD and the rest of the oscillators live in its indicator panels.
Full holdings
| Constituent | ISIN | Market value | Weight |
|---|---|---|---|
| Loading… | |||
Sector breakdown
Geographic exposure
Cost vs. peers
Comparison universe: 6,948 funds of the same asset class.
Cost impact calculator
Dividend history
Distributing share class Income is paid out to shareholders.
| Ex-date | Payment | Amount |
|---|---|---|
| 2026-06-25 | 2026-06-30 | USD 0.0920 |
| 2026-03-26 | 2026-03-31 | USD 0.0573 |
| 2025-12-12 | 2025-12-31 | USD 0.1294 |
| 2025-09-25 | 2025-09-30 | USD 0.1453 |
| 2025-06-26 | 2025-06-30 | USD 0.0892 |
| 2025-03-27 | 2025-03-31 | USD 0.0992 |
| 2024-12-13 | 2024-12-31 | USD 0.1304 |
| 2024-09-26 | 2024-09-30 | USD 0.1218 |
| 2024-06-27 | 2024-06-28 | USD 0.1284 |
| 2024-03-21 | 2024-03-28 | USD 0.0676 |
| 2023-12-22 | 2023-12-29 | USD 0.1232 |
| 2023-09-22 | 2023-09-29 | USD 0.0725 |
| 2023-06-27 | 2023-06-30 | USD 0.1179 |
| 2023-03-24 | 2023-03-31 | USD 0.1001 |
| 2022-12-23 | 2022-12-30 | USD 0.1253 |
| 2022-09-23 | 2022-09-30 | USD 0.0911 |
| 2022-06-24 | 2022-06-30 | USD 0.0384 |
| 2022-03-25 | 2022-03-31 | USD 0.0488 |
| 2021-12-23 | 2021-12-31 | USD 0.1101 |
| 2021-09-23 | 2021-09-30 | USD 0.0393 |
| 2021-06-24 | 2021-06-30 | USD 0.0533 |
| 2021-03-25 | 2021-03-31 | USD 0.0771 |
| 2020-12-24 | 2020-12-31 | USD 0.0644 |
| 2020-09-24 | 2020-09-30 | USD 0.0428 |
| 2020-06-25 | 2020-06-30 | USD 0.0463 |
| 2020-03-26 | 2020-03-31 | USD 0.0591 |
| 2019-12-13 | 2019-12-31 | USD 0.0411 |
| 2019-09-25 | 2019-09-30 | USD 0.0501 |
| 2019-06-14 | 2019-06-28 | USD 0.0395 |
| 2019-03-21 | 2019-03-29 | USD 0.0260 |
| 2018-12-18 | 2018-12-31 | USD 0.0367 |
| 2018-09-14 | 2018-09-28 | USD 0.0256 |
| 2018-06-21 | 2018-06-29 | USD 0.0354 |
| 2018-03-22 | 2018-03-29 | USD 0.0776 |
| 2017-09-21 | 2017-09-29 | USD 0.3801 |
| 2017-06-22 | 2017-06-30 | USD 0.0553 |
| 2017-03-23 | 2017-03-31 | USD 0.0313 |
| 2016-12-21 | 2016-12-30 | USD 0.0340 |
ESG profile
Benchmark: average of 4,066 funds of the same asset class with derived ESG data.
Similar ETFs
| Fund | TER | AUM (USD) | Yield (TTM) | Return 1y | Sharpe 1y |
|---|---|---|---|---|---|
| Vanguard Total Stock Market ETF VTI | 0.03% | 2.30T | 1.05% | +19.93% | 1.48 |
| Vanguard S&P 500 ETF VOO | 0.03% | 1.70T | 1.07% | +19.68% | 1.49 |
| iShares Core S&P 500 ETF IVV | 0.03% | 894.38B | 1.09% | +19.68% | 1.49 |
| State Street SPDR S&P 500 ETF SPY | 0.09% | 789.23B | 1.00% | +19.71% | 1.49 |
| SPDR S&P 500 ETF Trust 1557.T | 0.09% | 789.09B | 0.49% | +37.54% | 2.26 |
| State Street SPDR S&P 500 ETF SPY.AX | 0.09% | 788.13B | 1.00% | +11.84% | 1.13 |
| Vanguard Total International Stock ETF VXUS | 0.05% | 652.30B | 2.61% | +20.58% | 1.21 |
| Invesco QQQ Trust, Series 1 QQQ | 0.18% | 481.14B | 0.43% | +28.14% | 1.43 |
| Vanguard Growth ETF VUG | 0.03% | 393.80B | 0.39% | +16.85% | 0.99 |
| Vanguard FTSE Developed Markets ETF VEA | 0.03% | 317.30B | 2.60% | +21.64% | 1.23 |
Cheaper alternatives
No fund of the class reaches 60% portfolio overlap — showing the cheapest funds of the class instead.
| Fund | TER | AUM (USD) | Overlap |
|---|---|---|---|
| Vanguard Value ETF VTV | 0.03% | 245.00B | 7.6% |
| State Street SPDR Portfolio S&P 500 ETF SPYM | 0.02% | 159.32B | 5.1% |
| iShares Core S&P 500 UCITS ETF CSSPX.MI | 0.07% | 151.54B | 5.1% |
| iShares Core S&P 500 UCITS ETF SXR8.DE | 0.07% | 151.54B | 5.1% |
| iShares Core S&P 500 UCITS ETF CSPX.L | 0.07% | 151.69B | 5.1% |

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
